"We are stronger together! Based in Milwaukee, Versiti Blood Center of Wisconsin (formerly BloodCenter of Wisconsin) combines the strength of blood centers in Wisconsin, Indiana, Illinois, Michigan and Ohio with state-of-the-art diagnostic laboratories, physician services, and a world-renowned Blood Research Institute. Your blood will always stay local first, but now we will have even more access to rare and unique blood types to help meet the needs of Wisconsin hospital patients in need. Together, with you, we promise to continue our mission: we are a beacon of hope. About this location: The visitor parking lot (located on 18th Street) for this location is enclosed by a gate."

During the past decade, Versiti Wisconsin, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Versiti Wisconsin, Inc." #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Versiti Wisconsin, Inc." are "Pediatric Cancer" (1 trials), "Sickle Cell Disease" (1 trials), "Thalassemia" (1 trials) and "Warm Antibody Autoimmune Hemolytic Anemia" (1 trials). Many other conditions were trialed in "Versiti Wisconsin, Inc." in a lesser frequency.

Most popular intervention types in "Versiti Wisconsin, Inc." are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fostamatinib disodium" (1 trials), "Placebo" (1 trials) and "Red Blood Cell (RBC) Transfusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Versiti Wisconsin, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Versiti Wisconsin, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Versiti Wisconsin, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Versiti Wisconsin, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Versiti Wisconsin, Inc. has several departments that took part in Clinical trials: "Comprehensive Center for Bleeding Disorders" - 5 trials